Study shows crinecerfont aids patients with congenital adrenal hyperplasia
Crinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published June 2 in the New England Journal of ...
Jun 5, 2024
0
0